Iowamed spa & injectable regulations
What’s changing for med spas and injectors in Iowa — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in Iowa. Med Spa Radar monitors it all and tells you, in plain language, what changed and what to do.
Latest Iowa changes
- MONITORLegiScan2026-01-20
IA HSB591: A bill for an act establishing the medical spa oversight Act, and making penalties applicable.
New regulation may change operations for Iowa med spas.
Federal changes that apply in Iowa
FDA and Federal Register actions are nationwide — they govern Iowa practices too.
- CRITICALFEDERALFDA Enforcement2025-09-10
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
FDA recalls compounded GLP-1 product for being subpotent.
- CRITICALFEDERALFDA Enforcement2025-08-13
FDA recall (Class II): Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
FDA recalls compounded GLP-1 product; check your stock now!
- CRITICALFEDERALFDA Enforcement2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
FDA recalls Wegovy; med spas must check supplies!
- CRITICALFEDERALFDA Enforcement2026-03-11
FDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061,…
FDA recalls Semaglutide for sterility issues—act now!
- CRITICALFEDERALFDA Enforcement2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 B…
FDA recalls Wegovy due to safety concerns; med spas must act.
- CRITICALFEDERALFDA Enforcement2025-07-02
FDA recall (Class II): Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80…
FDA recalls GLP-1 product over sterility issues.
What we monitor in Iowa
- Iowa legislature — bills on injectables, GLP-1s & scope of practice
- Iowa Board of Nursing — injector scope & delegation
- Iowa Medical Board — physician supervision & ownership rules
- Iowa Board of Pharmacy — compounding & 503A/503B
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
Iowa med spa compliance — FAQ
- Where do Iowa med spa and injectable regulations come from?
- Iowa med spas and injectors are governed by a mix of state and federal authorities — the Iowa legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. Med Spa Radar monitors all of them for Iowa and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in Iowa?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in Iowa. We track those federal changes alongside any Iowa-specific rules so you see the full picture for your practice.
- How do I keep up with Iowa regulatory changes?
- Med Spa Radar sends a free weekly Brief on what changed across Iowa, the FDA, and the Federal Register. Members get the exact "what to do" for their states in real time. It's regulatory monitoring, not legal advice.
Never miss a Iowa change
Get the free weekly Brief on what changed across Iowa, the FDA, and the Federal Register. Members get the exact what-to-do, in real time, for their states.
Get the free Brief →← All states · Regulatory monitoring, not legal advice.